123 related articles for article (PubMed ID: 28881819)
21. The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.
Evans RP; Naber C; Steffler T; Checkland T; Maxwell CA; Keats JJ; Belch AR; Pilarski LM; Lai R; Reiman T
Br J Haematol; 2008 Feb; 140(3):295-302. PubMed ID: 18076711
[TBL] [Abstract][Full Text] [Related]
22. Nocturnal activation of aurora C in rat pineal gland: its role in the norepinephrine-induced phosphorylation of histone H3 and gene expression.
Price DM; Kanyo R; Steinberg N; Chik CL; Ho AK
Endocrinology; 2009 May; 150(5):2334-41. PubMed ID: 19116339
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a Pyrazolo[4,3-d]pyrimidine Inhibitor of Cyclin-Dependent Kinases 2 and 5 and Aurora A With Pro-Apoptotic and Anti-Angiogenic Activity In Vitro.
Řezníčková E; Weitensteiner S; Havlíček L; Jorda R; Gucký T; Berka K; Bazgier V; Zahler S; Kryštof V; Strnad M
Chem Biol Drug Des; 2015 Dec; 86(6):1528-40. PubMed ID: 26198005
[TBL] [Abstract][Full Text] [Related]
24. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S
Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669
[TBL] [Abstract][Full Text] [Related]
25. Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle.
Le LT; Couvet M; Favier B; Coll JL; Nguyen CH; Molla A
Oncotarget; 2015 Sep; 6(26):22152-66. PubMed ID: 26247630
[TBL] [Abstract][Full Text] [Related]
26. A Dual Non-ATP Analogue Inhibitor of Aurora Kinases A and B, Derived from Resorcinol with a Mixed Mode of Inhibition.
Karthigeyan D; Surabhi S; Mizar P; Soumik S; Banerjee A; Sinha SH; Dasgupta D; Narayana C; Kundu TK
Chem Biol Drug Des; 2016 Jun; 87(6):958-67. PubMed ID: 26808391
[TBL] [Abstract][Full Text] [Related]
27. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
28. Effects of KRC-108 on the Aurora A activity and growth of colorectal cancer cells.
Chung HJ; Park KR; Lee HJ; Lee J; Kim JH; Kim YC; Han SY
Biochem Biophys Res Commun; 2015 Jun; 461(4):605-11. PubMed ID: 25912878
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.
Manfredi MG; Ecsedy JA; Meetze KA; Balani SK; Burenkova O; Chen W; Galvin KM; Hoar KM; Huck JJ; LeRoy PJ; Ray ET; Sells TB; Stringer B; Stroud SG; Vos TJ; Weatherhead GS; Wysong DR; Zhang M; Bolen JB; Claiborne CF
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4106-11. PubMed ID: 17360485
[TBL] [Abstract][Full Text] [Related]
30. LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells.
Wang H; Li R; Li L; Ge Z; Zhou R; Li R
Biochem Biophys Res Commun; 2015 Feb; 458(1):201-7. PubMed ID: 25645017
[TBL] [Abstract][Full Text] [Related]
31. Validating Aurora B as an anti-cancer drug target.
Girdler F; Gascoigne KE; Eyers PA; Hartmuth S; Crafter C; Foote KM; Keen NJ; Taylor SS
J Cell Sci; 2006 Sep; 119(Pt 17):3664-75. PubMed ID: 16912073
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.
Wunderlich A; Fischer M; Schlosshauer T; Ramaswamy A; Greene BH; Brendel C; Doll D; Bartsch D; Hoffmann S
Cancer Sci; 2011 Apr; 102(4):762-8. PubMed ID: 21214672
[TBL] [Abstract][Full Text] [Related]
34. Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
Mori N; Ishikawa C; Senba M; Kimura M; Okano Y
Biochem Pharmacol; 2011 May; 81(9):1106-15. PubMed ID: 21371446
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells.
Ndolo KM; Park KR; Lee HJ; Yoon KB; Kim YC; Han SY
Immune Netw; 2017 Apr; 17(2):110-115. PubMed ID: 28458622
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma.
Wang X; Moschos SJ; Becker D
Genes Cancer; 2010 Sep; 1(9):952-63. PubMed ID: 21779474
[TBL] [Abstract][Full Text] [Related]
37. Cyclopenta[
Ekebergh A; Mårtensson J; Ekebergh CL
ACS Omega; 2020 Dec; 5(51):33455-33460. PubMed ID: 33403307
[TBL] [Abstract][Full Text] [Related]
38. Editorial: Characterization of esophageal cancer molecular signatures and mechanisms using multi-omics analyses.
Xu Y; Huang W; Tamadon A; Lin Y; Ye G
Front Genet; 2023; 14():1334569. PubMed ID: 38075700
[No Abstract] [Full Text] [Related]
39. Bladder cancer: aurora kinase inhibitors light up the therapeutic horizon in bladder cancer.
Fenner A
Nat Rev Urol; 2013 Apr; 10(4):184. PubMed ID: 23459035
[No Abstract] [Full Text] [Related]
40. Updates on the Treatment of Esophageal Cancer.
Patti MG
J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):751. PubMed ID: 27541277
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
